Recombinant BCG to Enhance Its Immunomodulatory Activities

Recombinant BCG to Enhance Its Immunomodulatory Activities

The bacillus Calmette–Guérin (BCG) is an attenuated <i>Mycobacterium bovis</i> derivative that has been widely used as a live vaccine against tuberculosis for a century. In addition to its use as a tuberculosis vaccine, BCG has also been found to have utility in the prevention or treatme...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Magdalena Kowalewicz-Kulbat, Camille Locht
Format:	Artykuł
Język:	English
Wydane:	MDPI AG 2022-05-01
Seria:	Vaccines
Hasła przedmiotowe:	rBCG cytokines tuberculosis bacterial toxins non-tuberculosis diseases
Dostęp online:	https://www.mdpi.com/2076-393X/10/5/827

Podobne zapisy

After 100 Years of BCG Immunization against Tuberculosis, What Is New and Still Outstanding for This Vaccine?
od: Mario Alberto Flores-Valdez
Wydane: (2021-12-01)

Priming with Recombinant BCG Expressing HTI Enhances the Magnitude and Breadth of the T-Cell Immune Responses Elicited by MVA.HTI in BALB/c Mice
od: Narcís Saubi, i wsp.
Wydane: (2020-11-01)

Decrease of IL-5 Production by Naive T Cells Cocultured with IL-18-Producing BCG-Pulsed Dendritic Cells from Patients Allergic to House Dust Mite
od: Magdalena Kowalewicz-Kulbat, i wsp.
Wydane: (2021-03-01)

Enhanced Glycosylation Caused by Overexpression of Rv1002c in a Recombinant BCG Promotes Immune Response and Protects against <i>Mycobacterium tuberculosis</i> Infection
od: Shufeng Weng, i wsp.
Wydane: (2024-06-01)

Comparison Between Simple Batch and Fed-Batch Bioreactor Cultivation of Recombinant BCG
od: Sarah Mendes, i wsp.
Wydane: (2024-11-01)

Recombinant BCG Expressing the Subunit 1 of Pertussis Toxin Induces Innate Immune Memory and Confers Protection against Non-Related Pathogens
od: Alex I. Kanno, i wsp.
Wydane: (2022-02-01)

BCG and protection against inflammatory and auto-immune diseases
od: Magdalena Kowalewicz-Kulbat, i wsp.
Wydane: (2017-07-01)

Recombinant BCG vaccine expressing multistage antigens of Mycobacterium tuberculosis provides long-term immunity against tuberculosis in BALB/c mice
od: Danang Fang, i wsp.
Wydane: (2024-12-01)

Fighting Tuberculosis: In Search of a BCG Replacement
od: Nonna I. Nadolinskaia, i wsp.
Wydane: (2022-12-01)

Recombinant BCG-LTAK63 Vaccine Candidate for Tuberculosis Induces an Inflammatory Profile in Human Macrophages
od: Carina C. dos Santos, i wsp.
Wydane: (2022-05-01)

BCG vaccination strategies against tuberculosis: updates and perspectives
od: Mengjin Qu, i wsp.
Wydane: (2021-12-01)

Contemporary aspects of tuberculosis in children without BCG vaccination
od: M. N. Kondаkovа, i wsp.
Wydane: (2021-04-01)

Protein Levels of Pro-Inflammatory Cytokines and Chemokines as Biomarkers of <i>Mycobacterium bovis</i> Infection and BCG Vaccination in Cattle
od: Hamza Khalid, i wsp.
Wydane: (2022-06-01)

The patterns of in vitro cell-death and inflammatory cytokines induced by distinct BCG vaccine strains are differentially induced in human mononuclear cells
od: C. Ponte, i wsp.
Wydane: (2018-01-01)

IV BCG Vaccination and Aerosol BCG Revaccination Induce Mycobacteria-Responsive γδ T Cells Associated with Protective Efficacy against <i>M. tb</i> Challenge
od: Alexandra L. Morrison, i wsp.
Wydane: (2023-10-01)

A dose escalation study to evaluate the safety of an aerosol BCG infection in previously BCG-vaccinated healthy human UK adults
od: Timothy Fredsgaard-Jones, i wsp.
Wydane: (2024-11-01)

Effectiveness Of BCG Vaccination in Prevention of Childhood Tuberculosis: A Prospective Study from Kishanganj, Bihar
od: Kashif Shahnawaz, i wsp.
Wydane: (2013-09-01)

Complications after BCG vaccination in a big city
od: T. A. Sevostyanova, i wsp.
Wydane: (2016-06-01)

Auxotrophic <i>Mycobacterium bovis</i> BCG: Updates and Perspectives
od: Odir Antônio Dellagostin, i wsp.
Wydane: (2022-05-01)

Specific and non-specific effects of Mycobacterium bovis BCG vaccination in dairy calves
od: Catalina Contreras, i wsp.
Wydane: (2023-10-01)

Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned
od: Athina Kilpeläinen, i wsp.
Wydane: (2018-11-01)

Characterization of the Protective Immune Responses Conferred by Recombinant BCG Overexpressing Components of <i>Mycobacterium tuberculosis</i> Sec Protein Export System
od: Annuurun Nisa, i wsp.
Wydane: (2022-06-01)

Identification of DNA methylation patterns predisposing for an efficient response to BCG vaccination in healthy BCG-naïve subjects
od: Jyotirmoy Das, i wsp.
Wydane: (2019-06-01)

Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection
od: Ming Zhang, i wsp.
Wydane: (2017-04-01)

Cobertura de vacunación de BCG en Sudamérica, 2010-2017: Distribución geográfica y su vínculo con la incidencia y mortalidad de tuberculosis
od: Kervyn Ynozente-Lázares
Wydane: (2024-06-01)

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates
od: Marco Polo Peralta Alvarez, i wsp.
Wydane: (2024-05-01)

BCG Vaccination and Spinal Tuberculosis in Non-Malnourished and/or Non-HIV Infected Children at Dr. Soetomo General Academic Hospital, Surabaya
od: Muhammad Abdir Rahman Albarok, i wsp.
Wydane: (2025-01-01)

Time to face the proofs: the BCG Moreau vaccine promotes superior inflammatory cytokine profile in vitro when compared with Russia, Pasteur, and Danish strains
od: Andreon Santos Machado da Silva, i wsp.
Wydane: (2022-01-01)

<i>Mycobacterium bovis</i> Wild-Type BCG or Recombinant BCG Secreting Murine IL-18 (rBCG/IL-18) Strains in Driving Immune Responses in Immunocompetent or Immunosuppressed Mice
od: Marek Fol, i wsp.
Wydane: (2022-04-01)

A review of the BCG vaccine and other approaches toward tuberculosis eradication
od: Thomas Cho, i wsp.
Wydane: (2021-08-01)

PROTECTIVE EFFECT INDUCED BY THE NEW SUBUNIT TUBERCULOSIS VACCINE WHEN USED AS A BCG BOOST IS ASSOCIATED WITH INHIBITION OF MYCOBACTERIAL DISSEMINATION
od: V. V. Yeremeev, i wsp.
Wydane: (2019-07-01)

ANÁLISE COMPARATIVA NO PERFIL DA COBERTURA VACINAL DOS IMUNIZANTES BCG ENTRE AS CAPITAIS BRASILEIRAS NO PERÍODO DE 2018-2022
od: Thamires Souza Pires, i wsp.
Wydane: (2023-10-01)

Factors influencing the efficacy of Bacille Calmette-Guérin (BCG) vaccine
od: Lwandile Bukula, i wsp.
Wydane: (2025-03-01)

Spatial co-distribution of tuberculosis prevalence and low BCG vaccination coverage in Ethiopia
od: Haileab Fekadu Wolde, i wsp.
Wydane: (2024-12-01)

Immune responses of cattle vaccinated by various routes with Mycobacterium bovis Bacillus Calmette-Guérin (BCG)
od: Mitchell V. Palmer, i wsp.
Wydane: (2025-01-01)

Cost-Effectiveness Analysis of BCG Vaccination against Tuberculosis in Indonesia: A Model-Based Study
od: Afifah Machlaurin, i wsp.
Wydane: (2020-11-01)

Comparison of the Immunogenicity and Efficacy of rBCG-EPCP009, BCG Prime-EPCP009 Booster, and EPCP009 Protein Regimens as Tuberculosis Vaccine Candidates
od: Ruihuan Wang, i wsp.
Wydane: (2023-11-01)

Effectiveness of booster BCG vaccination in preventing Covid-19 infection
od: lradj Amirlak, i wsp.
Wydane: (2021-11-01)

BCG: a vaccine with multiple faces
od: Marco Antonio Yamazaki-Nakashimada, i wsp.
Wydane: (2020-08-01)

Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?
od: Farzad Khademi, i wsp.
Wydane: (2018-01-01)